Kronos Bio Inc
NASDAQ:KRON

Watchlist Manager
Kronos Bio Inc Logo
Kronos Bio Inc
NASDAQ:KRON
Watchlist
Price: 0.9579 USD 3.21% Market Closed
Market Cap: 57.8m USD
Have any thoughts about
Kronos Bio Inc?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

KRON Price Targets Summary
Kronos Bio Inc

Wall Street analysts forecast KRON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRON is 1.6575 USD with a low forecast of 1.01 USD and a high forecast of 2.3625 USD.

KRON Lowest Forecast
Wall Street Target
1.01 USD
5% Upside
KRON Average Forecast
Wall Street Target
1.6575 USD
73% Upside
KRON Highest Forecast
Wall Street Target
2.3625 USD
147% Upside
Lowest
Price Target
1.01 USD
5% Upside
Average
Price Target
1.6575 USD
73% Upside
Highest
Price Target
2.3625 USD
147% Upside

KRON Last Price Targets
Kronos Bio Inc

The latest public price target was made on Nov 14, 2024 by Tyler Van Buren from Piper Sandler , who expects KRON stock to rise by 4% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Tyler Van Buren
Piper Sandler
1 USD
Upside 4%
1 month ago
Nov 14, 2024
Piper Sandler Downgrades Kronos Bio Inc. (KRON) to Neutral
StreetInsider
Robert Burns
H.C. Wainwright
2.25 USD
Upside 135%
7 months ago
May 3, 2024
Kronos Bio Inc. (KRON) PT Lowered to $2.25 at H.C. Wainwright
StreetInsider
Tyler Van Buren
Piper Sandler
Price Target 1 USD
Upside/Downside 4%
View Source
Robert Burns
H.C. Wainwright
Price Target 2.25 USD
Upside/Downside 135%
View Source
Kronos Bio Inc Competitors:
Price Targets
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
34% Upside
FYB
Formycon AG
80% Upside
TLX
Telix Pharmaceuticals Ltd
8% Upside
BPMC
Blueprint Medicines Corp
42% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
34% Upside
FYB
Formycon AG
80% Upside
TLX
Telix Pharmaceuticals Ltd
8% Upside
BPMC
Blueprint Medicines Corp
42% Upside
301080
Acrobiosystems Co Ltd
9% Upside
CCCC
C4 Therapeutics Inc
278% Upside
REGN
Regeneron Pharmaceuticals Inc
58% Upside
E
206650
EuBiologics Co Ltd
37% Upside

Revenue
Forecast

Revenue Estimate
Kronos Bio Inc

The compound annual growth rate of Kronos Bio Inc's revenue for the next 4 years is 25%.

N/A
Past Growth
25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Kronos Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Kronos Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

See Also

Summary
KRON intrinsic value, competitors valuation, and company profile.
DCF Valuation
KRON stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KRON stock valuation using valuation multiples.
Wall Street Estimates
KRON price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KRON stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KRON's stock price target?
Price Target
1.6575 USD

According to Wall Street analysts, the average 1-year price target for KRON is 1.6575 USD with a low forecast of 1.01 USD and a high forecast of 2.3625 USD.

What is Kronos Bio Inc's Revenue forecast?
Projected CAGR
25%

The compound annual growth rate of Kronos Bio Inc's revenue for the next 4 years is 25%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.